The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma

Conditions:   Relapsed and Refractory B Cell Lymphoma;   Non-Hodgkin Lymphoma Intervention:   Biological: CD20 CAR-T Sponsor:   Shanghai Longyao Biotechnology Inc., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials